Fulgent Genetics (FLGT) Other Non Operating Income (2023 - 2026)

Fulgent Genetics has reported Other Non Operating Income for 4 years, with the latest figure at $38000.0 in Q2 2026.

• Quarterly Other Non Operating Income fell 17.39% year-over-year to $38000.0 in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$4.0 million (down 698.35% YoY) and the FY2025 annual result came in at -$3.9 million, down 797.5% from the prior year.
• Other Non Operating Income climbed to $38000.0 in Q2 2026 per FLGT's latest filing, from $10000.0 in the prior quarter.
• Over five years, Other Non Operating Income peaked at $544000.0 in Q3 2024 and troughed at -$4.0 million in Q4 2025.
• A 4-year average of -$257500.0 and a median of $10500.0 in 2024 frame the typical range for Other Non Operating Income.
• The widest YoY moves for Other Non Operating Income: up 855.56% in 2025, down 57557.14% in 2025.
• Over 4 years, Other Non Operating Income stood at -$22000.0 in 2023, then surged by 131.82% to $7000.0 in 2024, then slumped by 57557.14% to -$4.0 million in 2025, then soared by 100.94% to $38000.0 in 2026.
• According to Business Quant data, Other Non Operating Income over the past three periods registered $38000.0, $10000.0, and -$4.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.